NEXT Financial Group, Inc - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 90 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$3,000
-100.0%
100
-75.0%
0.00%
-50.0%
Q2 2017$8,000,000
-33.3%
400
-33.3%
0.00%
-33.3%
Q1 2017$12,000,0000.0%6000.0%0.00%
+50.0%
Q4 2016$12,000,000
+149900.0%
600
+20.0%
0.00%
+100.0%
Q3 2016$8,000
+300.0%
500
+150.0%
0.00%0.0%
Q2 2016$2,000
-77.8%
200
-60.0%
0.00%
-66.7%
Q4 2015$9,000
-25.0%
5000.0%0.00%
-25.0%
Q3 2015$12,0005000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders